Sumitomo Mitsui Trust Group Inc. lessened its position in Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) by 0.5% in the 3rd quarter, according to its most recent filing with the SEC.

In a report released today, Balaji Prasad from Barclays maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a price target of $25.00. The company’s shares closed last Friday ...

We came across a bullish thesis on Teva Pharmaceutical Industries Limited (TEVA) on Kontra Investment Xchange’s Substack by ...

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

A POPULAR outdoor clothing chain is set to close six stores and has launched a huge closing down sale at each branch. Millets has launched clearance sales at six of its stores in recent weeks ...

Teva's long haul to a turnaround of its business ... have started to emerge as drivers of sales growth.

You’ll be forgiven for thinking you have to wait until the end of the month for Black Friday to find the best deal. But ...

Check out our top picks from Steam Next Fest October 2024 for an idea of what to expect when the next sale arrives. The best Steam feature for keeping track of sales is your wishlist. Browsing ...

Although the retail holiday doesn't take place until Friday, November 29, various retailers are already launching sales on TVs, laptops, running shoes, and more. The Tom's Guide team has decades ...